MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/cce.0000000000000827

Медицинская библиотека · Critical care explorations · 2022

Angiopoietin-Like4 Is a Novel Marker of COVID-19 Severity.

Bhatraju Pavan K, Morrell Eric D, Stanaway Ian B, Sathe Neha A, Srivastava Avantika, Postelnicu Radu, Green Richard, Andrews Adair, Gonzalez Martin, Kratochvil Christopher J, Kumar Vishakha K, Hsiang Tien-Ying, Gale Michael, Anesi George L, Wyles David, Broadhurst M Jana, Brett-Major David, Mukherjee Vikramjit, Sevransky Jonathan E, Landsittel Douglas, Hung Chi, Altemeier William A, Gharib Sina A, Uyeki Timothy M, Cobb J Perren, Liebler Janice M, Crosslin David R, Jarvik Gail P, Segal Leopoldo N, Evans Laura, Mikacenic Carmen, Wurfel Mark M

СтатьяПеревод в очереди

Аннотация

UNLABELLED: Vascular dysfunction and capillary leak are common in critically ill COVID-19 patients, but identification of endothelial pathways involved in COVID-19 pathogenesis has been limited. Angiopoietin-like 4 (ANGPTL4) is a protein secreted in response to hypoxic and nutrient-poor conditions that has a variety of biological effects including vascular injury and capillary leak.

OBJECTIVES

To assess the role of ANGPTL4 in COVID-19-related outcomes.

DESIGN SETTING AND

PARTICIPANTS

Two hundred twenty-five COVID-19 ICU patients were enrolled from April 2020 to May 2021 in a prospective, multicenter cohort study from three different medical centers, University of Washington, University of Southern California and New York University.

MAIN OUTCOMES AND MEASURES: Plasma ANGPTL4 was measured on days 1, 7, and 14 after ICU admission. We used previously published tissue proteomic data and lung single nucleus RNA (snRNA) sequencing data from specimens collected from COVID-19 patients to determine the tissues and cells that produce ANGPTL4.

RESULTS

Higher plasma ANGPTL4 concentrations were significantly associated with worse hospital mortality (adjusted odds ratio per log2 increase, 1.53; 95% CI, 1.17-2.00; p = 0.002). Higher ANGPTL4 concentrations were also associated with higher proportions of venous thromboembolism and acute respiratory distress syndrome. Longitudinal ANGPTL4 concentrations were significantly different during the first 2 weeks of hospitalization in patients who subsequently died compared with survivors (p for interaction = 8.1 × 10-5). Proteomics analysis demonstrated abundance of ANGPTL4 in lung tissue compared with other organs in COVID-19. ANGPTL4 single-nuclear RNA gene expression was significantly increased in pulmonary alveolar type 2 epithelial cells and fibroblasts in COVID-19 lung tissue compared with controls.

CONCLUSIONS AND RELEVANCE: ANGPTL4 is expressed in pulmonary epithelial cells and fibroblasts and is associated with clinical prognosis in critically ill COVID-19 patients.

Для цитирования: Bhatraju Pavan K, Morrell Eric D, Stanaway Ian B, Sathe Neha A, Srivastava Avantika, Postelnicu Radu, Green Richard, Andrews Adair, Gonzalez Martin, Kratochvil Christopher J, Kumar Vishakha K, Hsiang Tien-Ying, Gale Michael, Anesi George L, Wyles David, Broadhurst M Jana, Brett-Major David, Mukherjee Vikramjit, Sevransky Jonathan E, Landsittel Douglas, Hung Chi, Altemeier William A, Gharib Sina A, Uyeki Timothy M, Cobb J Perren, Liebler Janice M, Crosslin David R, Jarvik Gail P, Segal Leopoldo N, Evans Laura, Mikacenic Carmen, Wurfel Mark M. Angiopoietin-Like4 Is a Novel Marker of COVID-19 Severity.. Critical care explorations. 2022. DOI: 10.1097/cce.0000000000000827.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.